YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research.
YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research.
复制标题
DOI:
10.1093/nar/gku1156
复制
发表时间:
2015-01
影响因子:
14.9
通讯作者:
Wang HW
中科院分区:
文献类型:
--
作者:
Cheng WC;Chung IF;Tsai CF;Huang TS;Chen CY;Wang SC;Chang TY;Sun HJ;Chao JY;Cheng CC;Wu CW;Wang HW
We previously presented YM500, which is an integrated database for miRNA quantification, isomiR identification, arm switching discovery and novel miRNA prediction from 468 human smRNA-seq datasets. Here in this updated YM500v2 database (http://ngs.ym.edu.tw/ym500/), we focus on the cancer miRNome to make the database more disease-orientated. New miRNA-related algorithms developed after YM500 were included in YM500v2, and, more significantly, more than 8000 cancer-related smRNA-seq datasets (including those of primary tumors, paired normal tissues, PBMC, recurrent tumors, and metastatic tumors) were incorporated into YM500v2. Novel miRNAs (miRNAs not included in the miRBase R21) were not only predicted by three independent algorithms but also cleaned by a new in silico filtration strategy and validated by wetlab data such as Cross-Linked ImmunoPrecipitation sequencing (CLIP-seq) to reduce the false-positive rate. A new function ‘Meta-analysis’ is additionally provided for allowing users to identify real-time differentially expressed miRNAs and arm-switching events according to customer-defined sample groups and dozens of clinical criteria tidying up by proficient clinicians. Cancer miRNAs identified hold the potential for both basic research and biotech applications.
登录
查看更多内容
影响因子:
64.8
作者:
Lu, J;Getz, G;Golub, TR
通讯作者:
Golub, TR
影响因子:
11.2
作者:
Bader AG;Brown D;Winkler M
通讯作者:
Winkler M
影响因子:
12.3
作者:
Chen X;Li Q;Wang J;Guo X;Jiang X;Ren Z;Weng C;Sun G;Wang X;Liu Y;Ma L;Chen JY;Wang J;Zen K;Zhang J;Zhang CY
通讯作者:
Zhang CY
影响因子:
14.9
作者:
Humphreys DT;Suter CM
通讯作者:
Suter CM
影响因子:
2.8
作者:
Guo, Li;Zhao, Yang;Chen, Feng
通讯作者:
Chen, Feng